text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "natural killer"

0 Products found

You searched for "natural killer"

636 Documents found
  • Natural Killer Cells Infographic
    Natural Killer cells have an innate ability to recognize and destroy non-self cells.
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • 3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
  • Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity Assay
    Protocol instructions
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • TechSheet - Poietics™ Human Immune System Cells
    Technical Product Information Sheet
  • References - X-Vivo™
    Overview of relevant references
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • Normal Peripheral Blood CD4+ T Lymphocytes
    Lonza Application Notes
  • Application Example
    Analysis of undirected migration of NK cells
  • TechSheet - X-VIVO™ Media Systems
    Instructions for how to use the X-VIVO™ Media Series
  • Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic Research
    Lonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • Brochure - Cell List
    Integrated solutions for primary cells and transfection
  • Cell List – Integrated Solutions for Primary Cells and Transfection
  • Blood and Immune Cells
    Fueling your next discovery with unmatched cell and donor variety
  • Amaxa® Nucleofector® Technology - the Superior Non-Viral Method
    Lonza_Brochures_Amaxa_Nucleofector_Technology_-_the_Superior_Non-Viral_Method.pdf
  • 1(current)
  • 2
  • 3